Long non-coding RNA OTUD6B-AS1 overexpression inhibits the proliferation, invasion and migration of colorectal cancer cells via downregulation of microRNA-3171

Wang,Wei; Cheng,Xia; Zhu,Jianhua

doi:10.3892/ol.2021.12454

Long non-coding RNA OTUD6B-AS1 overexpression inhibits the proliferation, invasion and migration of colorectal cancer cells via downregulation of microRNA-3171

Authors:
- Wei Wang
- Xia Cheng
- Jianhua Zhu
View Affiliations

Affiliations: Department of Emergency Traumatic Surgery, Shanghai Pudong New District Zhoupu Hospital (Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital), Shanghai 201318, P.R. China, Graduate School, Dalian Medical University, Dalian, Liaoning 116000, P.R. China
Published online on: January 8, 2021 https://doi.org/10.3892/ol.2021.12454
Article Number: 193
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is a common digestive system malignancy and a major cause of cancer‑associated mortality worldwide. Aberrant expression of long non‑coding RNAs has been reported in several types of cancer. The aim of the present study was to investigate the role of ovarian tumor domain containing 6B antisense RNA1 (OTUD6B‑AS1) in CRC and its underlying mechanisms. OTUD6B‑AS1 expression in CRC cell lines was examined using reverse transcription‑quantitative PCR. Furthermore, The Cancer Genome Atlas database was utilized to examine the expression levels of OTUD6B‑AS1 in CRC tissues. Following OTUD6B‑AS1 overexpression, Cell Counting Kit‑8 and colony formation assays were used to detect the proliferation ability of HCT116 cells. The expression levels of proliferation‑related protein Ki67 were determined using immunofluorescence staining. Subsequently, Transwell and wound healing assays were used to evaluate the invasion and migration of HCT116 cells, respectively. The expression levels of migration‑related proteins (MMP2 and MMP9) were measured using western blotting. Additionally, a luciferase reporter assay was used to verify the potential interaction between OTUD6B‑AS1 and microRNA‑3171 (miR‑3171). Subsequently, rescue assays were performed to clarify the regulatory effects of OTUD6B‑AS1 and miR‑3171 on CRC development. The results demonstrated that OTUD6B‑AS1 expression was low in CRC cells and tissues. Overexpression of OTUD6B‑AS1 inhibited the proliferation, invasion and migration of HCT116 cells. Furthermore, miR‑3171 was demonstrated to be a direct target of OTUD6B‑AS1 using a luciferase reporter assay. The rescue assays revealed that miR‑3171 mimics markedly reversed the inhibitory effects of OTUD6B‑AS1 overexpression on proliferation, invasion and migration of CRC cells. Overall, these findings demonstrated that OTUD6B‑AS1 overexpression inhibited the proliferation, invasion and migration of HCT116 cells via downregulation of miR‑3171, suggesting that OTUD6B‑AS1 may serve as a novel biomarker for CRC treatment.

View Figures

View References

1	Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T: Colorectal cancer. Nat Rev Dis Primers. 1:15065. 2015. View Article : Google Scholar : PubMed/NCBI
2	Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global patterns and trends in colorectal cancer incidence and mortality. Gut. 66:683–691. 2017. View Article : Google Scholar : PubMed/NCBI
3	Zhou LL, Zou MD and Li WM: Recent advances in colorectal cancer-specific nucleic acid aptamers for diagnostic and therapeutic applications. Sci Adv Mater. 12:38–43. 2020. View Article : Google Scholar
4	The Lancet Oncology: Colorectal cancer: A disease of the young? Lancet Oncol. 18:4132017. View Article : Google Scholar
5	Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT and Merchea A: Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer. 18:e87–e95. 2019. View Article : Google Scholar : PubMed/NCBI
6	Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K, Liu X, Xu T, Sun L, Qin J, et al: LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Mol Cancer. 18:1352019. View Article : Google Scholar : PubMed/NCBI
7	Quinn JJ and Chang HY: Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
8	Rathinasamy B and Velmurugan BK: Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals. Biomed Pharmacother. 102:242–248. 2018. View Article : Google Scholar : PubMed/NCBI
9	Takata M, Pachera E, Frank-Bertoncelj M, Kozlova A, Jüngel A, Whitfield ML, Assassi S, Calcagni M, de Vries-Bouwstra J, Huizinga TW, et al: OTUD6B-AS1 might be a novel regulator of apoptosis in systemic sclerosis. Front Immunol. 10:11002019. View Article : Google Scholar : PubMed/NCBI
10	Wang Z, Xia F, Feng T, Jiang B, Wang W and Li X: OTUD6B-AS1 inhibits viability, migration, and invasion of thyroid carcinoma by targeting miR-183-5p and miR-21. Front Endocrinol (Lausanne). 11:1362020. View Article : Google Scholar : PubMed/NCBI
11	Wang G, Zhang ZJ, Jian WG, Liu PH, Xue W, Wang TD, Meng YY, Yuan C, Li HM, Yu YP, et al: Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway. Mol Cancer. 18:152019. View Article : Google Scholar : PubMed/NCBI
12	Mahesh G and Biswas R: MicroRNA-155: A master regulator of inflammation. J Interferon Cytokine Res. 39:321–330. 2019. View Article : Google Scholar : PubMed/NCBI
13	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
14	Wu Y, Yang L, Yu M and Wang J: Identification and expression analysis of microRNAs during ovule development in rice (Oryza sativa) by deep sequencing. Plant Cell Rep. 36:1815–1827. 2017. View Article : Google Scholar : PubMed/NCBI
15	Rane S, Sayed D and Abdellatif M: MicroRNA with a MacroFunction. Cell Cycle. 6:1850–1855. 2007. View Article : Google Scholar : PubMed/NCBI
16	Iorio MV and Croce CM: MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 9:8522017. View Article : Google Scholar : PubMed/NCBI
17	Wei Y, He R, Wu Y, Gan B, Wu P, Qiu X, Lan A, Chen G, Wang Q, Lin X, et al: Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues. Tumour Biol. 37:12555–12569. 2016. View Article : Google Scholar : PubMed/NCBI
18	Wang Z, Zhao Y, Wang Y and Jin C: Circular RNA circHIAT1 inhibits cell growth in hepatocellular carcinoma by regulating miR-3171/PTEN axis. Biomed Pharmacother. 116:1089322019. View Article : Google Scholar : PubMed/NCBI
19	Guo S, Zhu KX, Yu WH, Wang T, Li S, Wang YX, Zhang CC, Guo JQ, et al: SH3PXD2A-AS1/miR-330-5p/UBA2 ceRNAnetwork mediates the progression of colorectal cancer through regulating the activity of the Wnt/beta-catenin signaling pathway. Environ Toxicol. Oct 19–2020.(Epub ahead of print). doi: 10.1002/tox.23038. View Article : Google Scholar
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Li JH, Liu S, Zhou H, Qu LH and Yang JH: starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
22	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
23	Hua RX, Zhuo ZJ, Zhu J, Zhang SD, Xue WQ, Zhang JB, Xu HM, Li XZ, Zhang PF, He J, et al: XPG Gene Polymorphisms contribute to colorectal cancer susceptibility: A two-stage case-control study. J Cancer. 7:1731–1739. 2016. View Article : Google Scholar : PubMed/NCBI
24	He D, Ma L, Feng R, Zhang L, Jiang Y, Zhang Y and Liu G: Analyzing large-scale samples highlights significant association between rs10411210 polymorphism and colorectal cancer. Biomed Pharmacother. 74:164–168. 2015. View Article : Google Scholar : PubMed/NCBI
25	Global Burden of Disease Cancer Collaboration, ; Fitzmaurice C, Allen C, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, Fleming T, et al: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 3:524–548. 2017. View Article : Google Scholar : PubMed/NCBI
26	Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X, Tian X, Guo F, Liang Q, Liu Q, et al: LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun. 10:34992019. View Article : Google Scholar : PubMed/NCBI
27	Heo JB, Lee YS and Sung S: Epigenetic regulation by long noncoding RNAs in plants. Chromosome Res. 21:685–693. 2013. View Article : Google Scholar : PubMed/NCBI
28	Zhang H, Chen Z, Wang X, Huang Z, He Z and Chen Y: Long non-coding RNA: A new player in cancer. J Hematol Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI
29	Ma Y, Yang Y, Wang F, Moyer MP, Wei Q, Zhang P, Yang Z, Liu W, Zhang H, Chen N, et al: Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α. Gut. 65:1494–1504. 2016. View Article : Google Scholar : PubMed/NCBI
30	Cai B, Song XQ, Cai JP and Zhang S: HOTAIR: A cancer-related long non-coding RNA. Neoplasma. 61:379–391. 2014. View Article : Google Scholar : PubMed/NCBI
31	Galamb O, Barták BK, Kalmár A, Nagy ZB, Szigeti KA, Tulassay Z, Igaz P and Molnár B: Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors. World J Gastroenterol. 25:5026–5048. 2019. View Article : Google Scholar : PubMed/NCBI
32	Wang AH, Fan WJ, Fu L and Wang XT: LncRNA PCAT-1 regulated cell proliferation, invasion, migration and apoptosis in colorectal cancer through targeting miR-149-5p. Eur Rev Med Pharmacol Sci. 23:8310–8320. 2019.PubMed/NCBI
33	Zhang H, Song Y, Yang C and Wu X: Overexpression of lncRNA TUSC7 reduces cell migration and invasion in colorectal cancer. Oncol Rep. 41:3386–3392. 2019.PubMed/NCBI
34	Lin J, Chuang CC and Zuo L: Potential roles of microRNAs and ROS in colorectal cancer: Diagnostic biomarkers and therapeutic targets. Oncotarget. 8:17328–17346. 2017. View Article : Google Scholar : PubMed/NCBI
35	Liu Z, Wang Y, Borlak J and Tong W: Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades. Sci Rep. 6:237092016. View Article : Google Scholar : PubMed/NCBI
36	Gmerek L, Martyniak K, Horbacka K, Krokowicz P, Scierski W, Golusinski P, Golusinski W, Schneider A and Masternak MM: MicroRNA regulation in colorectal cancer tissue and serum. PLoS One. 14:e02220132019. View Article : Google Scholar : PubMed/NCBI
37	Nagy ZB, Barták BK, Kalmár A, Galamb O, Wichmann B, Dank M, Igaz P, Tulassay Z and Molnár B: Comparison of circulating miRNAs expression alterations in matched tissue and plasma samples during colorectal cancer progression. Pathol Oncol Res. 25:97–105. 2019. View Article : Google Scholar : PubMed/NCBI
38	Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat F, et al: MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell. 25:469–483. 2014. View Article : Google Scholar : PubMed/NCBI
39	Sun D, Yu F, Ma Y, Zhao R, Chen X, Zhu J, Zhang CY, Chen J and Zhang J: MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol Chem. 288:9508–9518. 2013. View Article : Google Scholar : PubMed/NCBI
40	Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X, Yu J, Guan X, Jiang BH and Liu LZ: Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. Biochim Biophys Acta. 1829:239–247. 2013. View Article : Google Scholar : PubMed/NCBI